News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hospira, Inc. (HSP), Fresenius SE Intensify Effort With FDA to Restock Leukemia Medicine


4/18/2011 7:07:48 AM

Bloomberg -- Hospira Inc. (HSP), Fresenius SE (FRE) and Boehringer Ingelheim GmbH are racing to restore U.S. supplies of a leukemia drug while regulators look to imports to meet patient demand. The Food and Drug Administration is working with the three companies to restore manufacturing levels for the medicine, cytarabine, and has found an overseas drugmaker willing to temporarily import the injections, Shelly Burgess, an agency spokeswoman, said yesterday. She declined to name the company because the product hasn’t been approved.

Read at Bloomberg

comments powered by Disqus
Bloomberg
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES